We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.24%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.5B
AUM Growth
-$7.73B
(-9.5%)
Cap. Flow
-$10.4B
Cap. Flow
% of AUM
-14.12%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
2,549
New
227
Increased
861
Reduced
712
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$301M |
| 2 |
Estee Lauder
EL
|
+$252M |
| 3 |
Boeing
BA
|
+$251M |
| 4 |
Kenvue
KVUE
|
+$174M |
| 5 |
Fidelity National Information Services
FIS
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$547M |
| 2 |
Union Pacific
UNP
|
+$459M |
| 3 |
Pinnacle West Capital
PNW
|
+$203M |
| 4 |
Wells Fargo
WFC
|
+$199M |
| 5 |
Bank of America
BAC
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Healthcare | 13.74% |
| 3 | Financials | 13.36% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $3.38M | ﹤0.01% |
129,874
| – | – |
|
602
Omnicell
OMCL
$1.64B
| $3.38M | ﹤0.01% |
74,973
-2,258
| -3% | -$137K |
|
603
Brinker International
EAT
$9.75B
| $3.37M | ﹤0.01% |
106,660
+3,979
| +4% | +$139K |
|
604
Intellia Therapeutics
NTLA
$1.57B
| $3.35M | ﹤0.01% |
106,150
-1,329
| -1% | -$51.6K |
|
605
American Water Works
AWK
$26.8B
| $3.35M | ﹤0.01% |
27,090
+24,119
| +812% | +$3.38M |
|
606
CrowdStrike
CRWD
$211B
| $3.35M | ﹤0.01% |
80,028
-191,848
| -71% | -$7.46M |
|
|
BCPC
607
Balchem Corp
BCPC
$5.75B
| $3.34M | ﹤0.01% |
26,958
-142
| -0.5% | -$18.9K |
|
608
Morgan Stanley
MS
$336B
| $3.34M | ﹤0.01% |
40,918
-1,286
| -3% | -$112K |
|
609
Factset
FDS
$9.77B
| $3.28M | ﹤0.01% |
7,513
-103
| -1% | -$43.9K |
|
610
Ameren
AEE
$30B
| $3.27M | ﹤0.01% |
43,779
-18,383
| -30% | -$1.5M |
|
611
Arcosa
ACA
$7.12B
| $3.25M | ﹤0.01% |
45,290
+38,223
| +541% | +$2.9M |
|
612
Becton Dickinson
BDX
$48.8B
| $3.19M | ﹤0.01% |
12,324
-2,109
| -15% | -$570K |
|
613
Akamai
AKAM
$17.2B
| $3.18M | ﹤0.01% |
29,816
+4,641
| +18% | +$462K |
|
614
West Pharmaceutical
WST
$24.5B
| $3.17M | ﹤0.01% |
8,444
-153
| -2% | -$59.2K |
|
|
INN
615
Summit Hotel Properties
INN
$724M
| $3.16M | ﹤0.01% |
545,142
-109,750
| -17% | -$655K |
|
616
Western Union
WU
$2.23B
| $3.16M | ﹤0.01% |
239,740
-8,174
| -3% | -$100K |
|
617
Dynatrace
DT
$14.2B
| $3.14M | ﹤0.01% |
67,276
+6,753
| +11% | +$332K |
|
618
Public Service Enterprise Group
PEG
$37.4B
| $3.14M | ﹤0.01% |
55,231
-116,609
| -68% | -$7.16M |
|
619
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $3.12M | ﹤0.01% |
79,487
+2,629
| +3% | +$107K |
|
620
Vanguard Short-Term Bond ETF
BSV
$44.6B
| – | – |
0
| – | – |
|
621
Martin Marietta Materials
MLM
$32.3B
| $3.1M | ﹤0.01% |
7,549
-37
| -0.5% | -$16.4K |
|
622
iShares Core S&P Total US Stock Market ETF
ITOT
$97.1B
| $3.1M | ﹤0.01% |
32,865
| – | – |
|
623
Health Catalyst
HCAT
$171M
| $3.09M | ﹤0.01% |
305,186
-9,124
| -3% | -$109K |
|
624
Neurocrine Biosciences
NBIX
$16.2B
| $3.06M | ﹤0.01% |
27,253
+25,393
| +1,365% | +$2.67M |
|
|
AGNT
625
AGNT Inc
AGNT
$690M
| $3.05M | ﹤0.01% |
188,030
+186,597
| +13,021% | +$3.85M |
|
Similar funds
QCM
Lazard Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Lazard Asset Management held 2,549 positions worth $73.5B, down 9.5% from $81.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $10.4B in Q3 2023, closing 243 positions and reducing 712 holdings. Its most notable exit was Littelfuse, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in ScottsMiracle-Gro worth $28.3M.
- Lazard Asset Management's largest Q3 2023 buy was ScottsMiracle-Gro: 548,310 shares worth $28.3M.
- Lazard Asset Management added most to PPL Corp in Q3 2023, an estimated $301M increase.
- Lazard Asset Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $547M.
- Lazard Asset Management fully exited Littelfuse in Q3 2023, selling an estimated $24.3M.
- Lazard Asset Management's ten largest holdings make up 24% of its $73.5B portfolio in Q3 2023.
- Lazard Asset Management opened 227 new positions and closed 243 in Q3 2023.
- Lazard Asset Management's portfolio value fell 9.5% quarter-over-quarter to $73.5B.
Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.